arrow
A

Anna Grazia Recchia

Universita degli Studi di Bari Aldo Moro
H指数:23
被引数:2,382

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia

淋巴细胞倍增时间是预测早期慢性淋巴细胞白血病首次治疗时间的关键预后因素

2021-08-029
OAAI
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases

靶向治疗时代的TP53破坏是危险因素: 525例慢性淋巴细胞白血病病例的多中心回顾性研究

2021-05-2511
OA
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients

慢性淋巴细胞白血病的首次治疗时间和P53功能障碍: 早期患者的O-CLL1研究结果

2020-10-2812
OAAI
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab

接受idelalisib-利妥昔单抗治疗的复发/难治性CLL患者的生存风险评分 (SRS) 的验证

2020-09-1612
OAAI
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study
LEUKEMIA
IF13.4
2020-04-1421
PREAI
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
2020-02-2721
OAAI
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant

高剂量美法仑和自体干细胞移植后,对多发性骨髓瘤患者进行非格司亭的比较研究

2019-12-184
PREAI
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases
2018-07-3016
OAAI
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab
LEUKEMIA
IF13.4
2018-03-208
PREAI
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence

IL-23R/IL-23轴的微环境调节超越了慢性淋巴细胞白血病的惰性

2018-02-1416
OAAI
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases
2017-11-2318
OAAI
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
2017-01-2322
OAAI
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy

miRNA-15和miRNA-16表达替代在慢性淋巴细胞白血病中的作用: 对治疗的意义

LEUKEMIA
IF13.4
2017-01-0531
PREAI
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients

进展风险评分预测早期慢性淋巴细胞白血病患者的无治疗生存期

LEUKEMIA
IF13.4
2015-12-0930
PREAI